Cleviprex FDA Approval History
FDA Approved: Yes (First approved August 1, 2008)
Brand name: Cleviprex
Generic name: clevidipine butyrate
Dosage form: Injectable Emulsion
Company: The Medicines Company
Treatment for: High Blood Pressure
Cleviprex (clevidipine) is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.
Development timeline for Cleviprex
|Aug 4, 2008||Approval The Medicines Company’s Cleviprex Receives FDA Approval|
|Sep 14, 2007||FDA Accepts NDA Filing for Cleviprex (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.